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These two groups were not different according to age, diabetes or
cardiovascular event history but had a signiﬁcant higher interdialytic weight
gain and protein intake. In the Cox model analysis the patient overall
mortality was related to age (po0.0001), to the W52W8 BW D (p¼0.017), to
the CRP level at W52 (p¼0.035) and to serum albumin at W52 (p¼0.036).
Hence weight gain during the ﬁrst year of HD treatment was found a strong
predictor of survival in HD patients. It was associated with a better food
intake whereas the patient case-mix was not different. These data highlight
the need for understanding what drives food intake in dialysis patients and
for careful nutritional follow-up and support in incident HD patients.
http://dx.doi.org/10.1016/j.krcp.2012.04.355
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BODY WEIGHT CHANGE DURING THE FIRST YEAR OF HEMODIALYSIS IS
INFLUENCED BY THE DRY WEIGHT QUEST
Charles Chazot, Patrik Deleaval, Anne-Lise Bernollin, Cyril Vo-Van,
Guillaume Jean
NephroCare Tassin-Charcot, France
Fluid overload, high blood pressure (BP) and nutrition disturbances may
improve after HD onset. However HD patients remain exposed to a high
risk of death. We report the relationship between the dry weight quest and
nutritional markers on the survival in incident HD patients.
Among a cohort including 308 patients stating HD therapy 251
(age¼65,8714,8 y.o.; F/M¼93/158; diabetes¼36%) survived at least one
year after dialysis onset and were followed for an average of 44,9 months.
During the ﬁrst 8 weeks, the prescribed BW decreased by 6.575.6% and
then started to increase again. From Week 8 (W8) to W52, the BW change
(D) wasþ1,977,4% (extremes:–24,6 toþ28,2%). Serum albumin and nPNA
changed respectively byþ7.8 andþ11.4%. (þ7.6% vs–3.6%, p¼0.0001). The
initial W8-W1 BW D (expressed as % of the BW at HD onset) was
signiﬁcantly correlated with the systolic BP D at W26 and W52
(respectively p¼0.0007 and 0.0033). It was also inversely correlated with
the D in serum albumin and nPNA (p¼0.002 and 0.04) but not with BW D
between W8 and W52. The W52W8-BW D and the W52-W1-systolic BP D
were signiﬁcantly correlated (r¼–0,14, p¼0.03). When the patients were
split in two groups according the median of systolic BP change (–20.8 vs
þ7.8%), the W52W8 BW D was signiﬁcantly higher in the group of the
larger systolic BP decrease (þ3.3 vs þ0.6%, p¼0.004).
Hence weight gain during the ﬁrst year of HD treatment that is a strong
predictor of survival in our experience (reported in another abstract) is
inﬂuenced by the dry weight quest. In our practice, the systolic BP decrease
is related to ﬂuid removal and is associated with better patient survival,
opposite to the reverse epidemiology concept. Further studies using
bioimpedance are necessary to conﬁrm that an optimal ﬂuid status may
improve the nutritional status in HD patients.
http://dx.doi.org/10.1016/j.krcp.2012.04.356
33
A COMPARISON OF PROGRESSION OF CHRONIC RENAL FAILURE: LOW
DOSE VS STANDARD DOSE KETOACIDS
Jin-Bor Chen 1, Ben-Chung Cheng 2, Tze-Wah Kao 2
1 Kaohsiung Chang Gung Memorial Hospital and Chang Gung University
College of Medicine, Kaohsiung, Taiwan
2 National Taiwan University Hospital
Purpose: It has been documented that a low protein diet (LPD) with
ketoacid analogues (one ketosterils /5 kg) can postpone dialysis therapy in
chronic kidney disease. The purpose of the study was to compare the
effects of residual renal function preservation between low dose (one
ketosterils /10 kg) and standard dose (one ketosterils /5 kg) ketoacid
analogues.
Methods: The study was a prospective, open-label, group-comparison
design. The duration was 6 months. Patients were enrolled in two hospitals
when the serum Cr more than 6 mg/dL (CKD stage 4,5). Then the enrolled
patients were randomized to three groups, LPD, LPDK1 (LPD þ standard
dose ketosterils), LPDK2 (LPD þ low dose ketosterils). The deﬁnition of
LPD was 0.6-0.8 gm of protein/kg body weight/day. The comparable
variables were routine hemogram, bio-chemistry data, iPTH, reciprocal Cr
(1/Cr), (eGFR), UN/Cr levels in 24-hr urine (UUN/UCr). The measurements
were performed in baseline and 6th month.
Results: Demographics of patients were LPD: 22 (M/F:10/12), 49.5 y/o,
BMI 21.573.3; LPDK1:21 (8/13), 53.6 y/o, BMI 22.773.5; LPDK2:37 (15/
22), 62 y/o (p:o0.0001), BMI 25.874.7 (p:0.001). The signiﬁcant variables
in the baseline between groups as follows: BUN 76.2726.9, 70.6717.6,
94.0725.7 mg/dL (p:0.001); Cr 8.872.8, 8.071.4, 8.772.5 mg/dL (NS);
K 4.470.8, 4.770.7 4.970.8 mEq/L (p:0.047), albumin 4.670.4, 4.570.3,
4.070.4 gm/dL (p:o0.001). The levels of 1/Cr from baseline to the 6th
month in LPD, LPDK1, LPDK2 demonstrated a signiﬁcant decline: 0.13-
0.11, slope 0.0032; 0.13-0.11, slope -0.003; 0.13-0.12, slope 0.002.
However, levels of UUN/UCr and eGFR did not reveal signiﬁcant changes.
UUN/UCr: 5.76-5.88, slope 0.0195, 6.45-6.21, slope 0.0397, 6.27-
6.57, slope 0.05. eGFR: 6.16-5.77, slope 0.065; 6.19-5.35, slope 0.12;
5.73-5.41, slope 0.053.
Conclusions: The 6-month observation study showed low dose ketoacid
analogues combined with LPD had a beneﬁcial effect to slow down renal
function deterioration in CKD stage 4,5. However, the slope of 1/Cr levels in
low dose ketoacid analogues was less than that in standard dose ketoacid
analogues.
http://dx.doi.org/10.1016/j.krcp.2012.04.357
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ANTI-INFLAMMATORY EFFECTS OF LOW PROTEIN DIET SUPPLEMENTED
WITH KETO-AMINO ACID IN THE TREATMENT OF TYPE
2 DIABETIC NEPHROPATHY
Nan Chen, Yuanmeng Jin, Hong Ren, Jing Xu, Pingyan Shen, Xiaomin Huang
Department of Nephrology, Ruijin Hospital, Shanghai Jiao Tong University,
School of Medicine, 200025, Shanghai, P.R.China
Recent clinical research strongly approves that low-protein diet
supplemented with keto-amino acid can effectively delay progression of type
2 diabetic nephropathy (DN). Anti-inﬂammation is one of these effects, but the
mechanism is still controversial. This study is designed to further explore roles
of ketogenic diets in regulation of inﬂammation status of type 2 DN. Twenty-
one patients with type 2 DN (mean age at 65.1477.34 years), were followed-
up for 52 weeks in this study. All patients were in CKD stages 3–4 with
glomerular ﬁltration rates 26–55ml/min/1.73 m2 and were all on a low-
protein diet containing 0.8 g protein/kg BW per day and 30–35 Kcal /kg BW per
day. The diet was randomly supplemented with keto-amino acids at a dosage
of 100 mg/kg BW per day in 10 patients, who were assigned into Group II.
Other 11 patients were assigned into Group I. At the end of this study, related
clinical data showed there was a signiﬁcant increase in the serum level of TNF-
a which could mediate inﬂammation systemically in Group I (from
230.25754.34 to 332.11 pg/ml, P o 0.01), but non-signiﬁcant increase in
Group II (from 224.59741.24 to 253.41731.28 pg/ml, P40.05). The level of
CRP, which is produced in response to inﬂammation, rose greatly in Group I
(from 7.571.07 to 20.473.72 ug/ml, P o 0.01), but decreased in Group II
(from 8.273.07 to 3.971.22 ug/ml, P o 0.01). The level of adiponectin, an
anti-inﬂammatory factor, was decreased in Group I (from 9.4270.8 to
7.6471.4 mg/ml, Po 0.05), but showed slight increase in Group II (9.0470.9
versus 10.4771.2¼ mg/ml, P40.05). Nutritional markers including serum
albumin, hemoglobin and basal metabolic index showed no malnutrition
happened during the follow-up period. In conclusion, low-protein diet
supplemented with keto-amino acids contribute to ameliorate inﬂammation in
the progression of type 2 diabetic nephropathy through regulating
inﬂammatory factors production, including TNF-a, CRP and adiponectin.
http://dx.doi.org/10.1016/j.krcp.2012.04.358
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IMPACT OF DIETARY PROTEIN EXCHANGE 0N PATIENT’S COMPLIANCE,
APPLICABILITY AND EFFICIENCY IN CHRONIC KIDNEY DISEASE
Wei Chen, Hai-long Li, Sai-nan Zhu
Peking Union Medical College Hospital
The application of Low Protein Diet (LPD) in the treatment of CKD has been
more accepted by all medical stuffs nowadays. However, the diversity and
complexity of therapeutic diet as well as being difﬁcult to obtain more
detailed consultation have caused poor long-term maintenance and
compliance in most patients.To investigate patient’s compliance to dietary
therapy as well as the impact of Dietary Protein Exchange (DPE) on patient’s
compliance in CKD patients.To investigate patient’s self understanding and
prehension to educational resources on DPE in CKD patients.CKD patients are
diagnosed in clinics from 6 hospitals according to the random digits table. 200
enrolled patients are randomly divided into test groups and control groups
after signing the concent forms.Test groups:Face to face education of the
utilization of new DPE as well as attentions in follow-up is conducted by
Kidney Res Clin Pract 31 (2012) A16–A96A24
dietitians.Control groups:Regular face to face counseling as well as attentions
in follow-up is conducted by dietitians.Time arrangement for follow-up,3
times within 24 weeks (week 4, 12 and 24 respectively).180 cases completed
the trail. Compared with control group, the test group patients’s compliance
with DPI was better, 58.576.8 gvs45.678.9 g po0.05).The knowledge of
diet protein score was higher than the control group, 19.474.5 vs
11.373.2,Po0.01).The clinical data still had no difference.In Conclusion,the
DPE is a new good tool for Chinese CKD patients.
http://dx.doi.org/10.1016/j.krcp.2012.04.359
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IMPACT OF RESIDUAL RENAL FUNCTION ON CHANGES OF BODY
COMPOSITION IN DIABETIC CAPD PATIENTS
Kyu-Hyang Cho, Jun-Young Do, Soek-Hui Kang, Jong-Won Park, Kyung-
Woo Yoon
Department of Internal Medicine, Yeungnam University Hospital, Daegu, Korea.
Purpose: Preservation of residual renal function (RRF) in peritoneal
dialysis patient is essential to improve clinical outcomes. Therefore, we
conducted a prospective observational study to investigate the effect of low
RRF in early period on body composition changes in CAPD patients.
Methods: Among new diabetic CAPD patients from May 2001 to December
2009 in our hospital, 92 patients who ﬁnished 12 month protocol (male:
48, mean age: 54.0711.0 years) were analyzed. Patients were assigned to
4 different dialysis solution (Dianealsn¼30, Physionealsn¼15 and Stay-
safesn¼15, Stay-safe Balances, n¼32). We deﬁned the early low RRF
group (n¼10) as less than 1.5 ml/min 1.73 m2 at 4 weeks after initiation of
peritoneal dialysis. Daily ultraﬁltration volume (UFV) and urine volume
(UV), daily peritoneal glucose absorption, adequacy, residual renal function
(RRF) and clinical indices were measured at 4 weeks and 12 months. The
peritoneal equilibration test (PET) were performed at 4 weeks and 12
months. Body composition including body weight (BW), lean body mass
(LBM) and fat mass were measured using bio-impedance analysis (BIA) at
4 weeks and 12 months. Delta LBM was calculated as LBM at 12 months
minus LBM at 4 weeks. We analyzed the data by SPSS 17.0. Results: 1)
Baseline characteristics between the early low RRF group and the non-early
low RRF group were not signiﬁcantly different. 2) There was signiﬁcant
positive correlation between RRF at 4 weeks and RRF at 12 months
(po0.01). 3) The early low RRF group showed signiﬁcant lower delta LBM
than non-early low RRF group (3.1 vs. 0.95 kg, po0.05) There were no
signiﬁcant differences in body weight and fat mass between the two
groups. 4) The early low RRF group showed signiﬁcant lower serum
albumin than non-early low RRF group (3.25 vs. 3.59 g/dl, po0.05) at 12
months. Conclusions: The low RRF in early period of peritoneal dialysis
might be associated with body composition changes during the ﬁrst year in
CAPD patients. It is suggested that preservation of RRF in early period of
peritoneal dialysis is important to improve nutritional status.
http://dx.doi.org/10.1016/j.krcp.2012.04.360
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EFFECTS OF A KETO/AMINO ACID SUPPLEMENTED LOW PROTEIN DIET
ON THE DELAY OF PROGRESSIEVE RENAL FAILURE IN CHRONIC
KIDNEY DISEASE
Hoon Young Choi 1, Yong Kyu Lee 2, Beom Seok Kim 1, Hyeong Cheon Park 1,
Sug Kyun Shin 2, Sung Kyu Ha 1, Hyun Chul Kim 3, Ho Yung Lee 1
1 Department of Internal Medicine, Yonsei University College of Medicine,
Seoul, Korea
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A protein-restricted diet with keto/amino acids (KA) supplement showed
favorable effects on delayed renal replacement therapy in patients with
chronic kidney disease. This is an open, prospective, randomized, and
multi-center study. A total of 67 patients were randomly assigned into two
groups. LPDþKA group was advised to take less than 0.6 g/kg/day of
protein with KAs. LPD group was advised to consume less than 0.6 g/kg/day
protein. Nutritional and clinical parameters were evaluated at baseline,
3 and 6 months. Nutritional status represented as body mass index, mid-
arm circumference and triceps skin-fold thickness was not different
between the two groups at 3months and 6 months. Ca P product level
measured at 3 months was lower in the LPDþKA group than in the LPD
group (LPDþKA group: 33.575.0 vs. LPD group: 36.977.9 mg2/dL2,
po0.05). The slope of the glomerular ﬁltration rate (GFR slope) and the
percentage of the GFR slope (GFR slope %) at 3 months were more
preserved in the LPDþKA group than in the LPD group. The GFR slope and
GFR slope % at 6 months were not signiﬁcantly different. In the entire
subjects, the GFR slope was negatively correlated with Ca P product
levels at 3 months, total cholesterol at baseline, and urine protein-
creatinine ratio at baseline and 6 months (r¼0.255, r¼0.296, r
¼0.412, r¼0.371, po0.05). A multiple regression analysis revealed
CaP product at 3 months was the only independent factor affecting the
GFR slope at 3 months. The present study suggests that a low protein diet
supplemented with KA had a beneﬁcial effect on preserving renal function
and improving calcium and phosphorus disturbances in patients with
chronic kidney disease.
http://dx.doi.org/10.1016/j.krcp.2012.04.361
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DOSE BODY FAT MASS DEFINE SURVIVAL IN PATIENTS STARTING
PERITONEAL DIALYSIS?
Soo Jeong Choi, Soon Mi Hur, Kyong-Ah Park, Moo Yong Park, Jin Kuk Kim,
Seung Duk Hwang
Soonchunhyang Universtiy Bucheon Hospital, Bucheon-si, Gyeonggi-do, South
Korea
Peritoneal dialysis (PD) is characterized by a gain in fat mass. In contrast
to subcutaneous fat, visceral fat is associated with metabolic syndrome and
survival. We prospectively examined whether the visceral or subcutaneous
fat could deﬁne outcomes in patients undergoing PD. We studied 105 new
patients (51 males) undergoing PD between February 2006 and April 2011.
Baseline body composition was measured by computed tomogram.
Visceral and subcutaneous obesity are deﬁned as a visceral fat area
41100 cm2 and subcutaneous fat area 41130 1cm2, respectively. Thirty-
three and 25 patients were diagnosed with visceral and subcutaneous
obesity, respectively. Nineteen patients had both visceral and
subcutaneous obesity. The 1-year and 5-year survival rates were 91% and
75%, respectively. The peritonitis and exit infection rates were 0.36 and
0.13/patient-year, respectively. Patients with visceral obesity had poor
outcomes compared with those without visceral obesity (p¼0.025).
Subcutaneous obesity was not associated with peritonitis or survival. A
multivariate Cox regression analysis did not show that visceral obesity was
a risk factor of poor outcome. Increased visceral fat at the initiation of PD is
not an independent predictor of poor outcome. The impact of visceral or
subcutaneous mass for outcomes in patients undergoing PD would be
better deﬁned by large and long term studies.
http://dx.doi.org/10.1016/j.krcp.2012.04.362
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